Clovis Oncology reported $606.48M in Market Capitalization for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Market Capitalization Change
Abbvie ABBV:US $ 198.95B 7.96B
Acadia Pharmaceuticals ACAD:US $ 3.91B 222.46M
Acceleron Pharma XLRN:US $ 7.62B 606.02M
Acorda Therapeutics ACOR:US $ 45.26M 955.08K
Agenus AGEN:US $ 1.22B 664.46M
Agios Pharmaceuticals AGIO:US $ 3.39B 211.72M
Anika Therapeutics ANIK:US $ 623M 38.49M
Arrowhead Research ARWR:US $ 8.62B 1.74B
AstraZeneca AZN:LN 113.99B 18.86B
Astrazeneca AZN:US 157.61B 26.53B
Cerulean Pharma CERU:US $ 93.27M 13.31M
Clovis Oncology CLVS:US $ 606.48M 127.32M
Eli Lilly And LLY:US $ 220.12B 40.96B
Enanta Pharmaceuticals ENTA:US $ 888.79M 106.09M
Esperion Therapeutics ESPR:US $ 596.26M 193.51M
Five Prime Therapeutics FPRX:US $ 1.77B 1.02B
GlaxoSmithKline GSK:LN 71.42B 6.62B
Gw Pharmaceuticals GWPH:US 6.44B 2.84B
Halozyme Therapeutics HALO:US $ 6.47B 491.5M
Heron Therapeutics HRTX:US $ 1.58B 98.85M
Insmed INSM:US $ 3.22B 293.47M
Intrexon XON:US $ 1.35B 76.37M
Ligand Pharmaceuticals LGND:US $ 2.18B 347.98M
Merk MRK:US $ 196918.18M 1780.24M
Mirati Therapeutics MRTX:US $ 8.31B 483.81M
Neurocrine Biosciences NBIX:US $ 9.2B 7.62M
Novartis NOVN:VX 208.02B 8.76B
Pfizer PFE:US $ 219205.69M 17108.81M
Puma Biotechnology PBYI:US $ 370.52M 20.79M
Rigel Pharmaceuticals RIGL:US $ 738.51M 156.7M
Sangamo Biosciences SGMO:US $ 1.72B 78.47M
Seattle Genetics SGEN:US $ 28.65B 3.48B
Ultragenyx Pharmaceutical RARE:US $ 6.43B 1.19B
Veracyte VCYT:US $ 2.69B 912.75M
YTE INCY:US $ 18.5B 632.77M